Among women with previously treated, locally recurrent or metastatic breast cancer, treatment with the chemotherapy drug Halaven™ (eribulin mesylate) improved overall survival by 2.5 months. The results of this Phase III clinical trial were published in The Lancet. Metastatic breast …
Tag: breast cancer
Mammography Less Accurate for Detection of Second Cancers
Among women with a personal history of breast cancer, mammography can detect second cancers at an early stage, but may be less accurate than among women who have never had breast cancer. These results were published in the Journal of …
Obesity Linked with Triple-Negative Breast Cancer
Women who are obese and not physically active may be more likely than other women to develop triple negative breast cancer (breast cancer that is estrogen receptor negative, progesterone receptor negative, and HER2 negative). These results were published in Cancer …
Surgical Breast Biopsies Being Overused
A study conducted in Florida suggests that too many women are undergoing open, surgical breast biopsies instead of less invasive needle biopsies. These results were published in the American Journal of Surgery. If a woman has a breast lump …
Hormone Use Near Menopause May Pose Greatest Breast Cancer Risk
A large study conducted in the UK has reported that early use of menopausal hormone therapy (use before or soon after menopause) may increase breast cancer risk to a greater extent than later use. These results were published in the …
Social Support May Improve Breast Cancer Outcomes
Social well being during the first year after a breast cancer diagnosis may have a beneficial effect on cancer outcomes. These results were published in the Journal of Clinical Oncology. A diagnosis of breast cancer often affects a woman’s
Study Evaluates Predictors of DCIS Outcomes
Choice of treatment, choice of surgeon, and surgical margin (a measure of whether the cancer was completely removed) all appear to affect the risk of disease recurrence among women with ductal carcinoma in situ (DCIS) of the breast. These findings …
Lasofoxifene Promising for Breast Cancer Prevention Among Postmenopausal Women with Osteoporosis
Lasofoxifene, a selective estrogen receptor modulator (SERM), appears to reduce the risk of breast cancer among postmenopausal women with osteoporosis. These findings were recently reported in the Journal of the National Cancer Institute. As a SERM, the investigational drug lasofoxifene …
Breast Cancer PSA 2011
Binoculars for a Cause Alpen Pink 393p for Breast Cancer Video!
binocularexpress.com Alpen PINK 393P 10×42 Binoculars Model: 393P Shipping Method: Free Shipping Products Condition: New Manufacturer: Alpen Why PINK? Pink is the color most associated with breast cancer research. With more than 40000 Americans dying each year of breast cancer,…
Source: YouTube